Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer
Mads Gyrd‐Hansen, Pascal Meier
Nature reviews. Cancer (2010) Vol. 10, Iss. 8, pp. 561-574
Closed Access | Times Cited: 735

Showing 26-50 of 735 citing articles:

Apoptotic cell signaling in cancer progression and therapy
Jessica Plati, Octavian Bucur, Roya Khosravi‐Far
Integrative Biology (2011) Vol. 3, Iss. 4, pp. 279-296
Open Access | Times Cited: 291
An Activity-Guided Map of Electrophile-Cysteine Interactions in Primary Human T Cells
Ekaterina V. Vinogradova, Xiaoyu Zhang, David Remillard, et al.
Cell (2020) Vol. 182, Iss. 4, pp. 1009-1026.e29
Open Access | Times Cited: 283
Hyaluronan-CD44v3 Interaction with Oct4-Sox2-Nanog Promotes miR-302 Expression Leading to Self-renewal, Clonal Formation, and Cisplatin Resistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma
Lilly Bourguignon, Gabriel Wong, Christine Earle, et al.
Journal of Biological Chemistry (2012) Vol. 287, Iss. 39, pp. 32800-32824
Open Access | Times Cited: 279
NLR functions beyond pathogen recognition
Thomas A. Kufer, Philippe Sansonetti
Nature Immunology (2011) Vol. 12, Iss. 2, pp. 121-128
Closed Access | Times Cited: 274
A Time to Kill: Targeting Apoptosis in Cancer
Jean L. Koff, Sampath Ramachandiran, Leon Bernal‐Mizrachi
International Journal of Molecular Sciences (2015) Vol. 16, Iss. 2, pp. 2942-2955
Open Access | Times Cited: 262
Regulation of cell death and autophagy by IKK and NF‐κB: critical mechanisms in immune function and cancer
Albert S. Baldwin
Immunological Reviews (2012) Vol. 246, Iss. 1, pp. 327-345
Closed Access | Times Cited: 261
Regulation of Human Neutrophil Apoptosis and Lifespan in Health and Disease
Jenna McCracken, Lee‐Ann H. Allen
Journal of Cell Death (2014) Vol. 7, pp. JCD.S11038-JCD.S11038
Open Access | Times Cited: 260
Small-Molecule Modulation of Protein Homeostasis
George M. Burslem, Craig M. Crews
Chemical Reviews (2017) Vol. 117, Iss. 17, pp. 11269-11301
Closed Access | Times Cited: 255
Degradation of proteins by PROTACs and other strategies
Yang Wang, Xueyang Jiang, Feng Feng, et al.
Acta Pharmaceutica Sinica B (2019) Vol. 10, Iss. 2, pp. 207-238
Open Access | Times Cited: 254
A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment
Qian Cai, Haiying Sun, Yuefeng Peng, et al.
Journal of Medicinal Chemistry (2011) Vol. 54, Iss. 8, pp. 2714-2726
Open Access | Times Cited: 253
Checkpoints in TNF-Induced Cell Death: Implications in Inflammation and Cancer
Alessandro Annibaldi, Pascal Meier
Trends in Molecular Medicine (2017) Vol. 24, Iss. 1, pp. 49-65
Closed Access | Times Cited: 244
The Inflammation and Liver Cancer
Anupam Bishayee
Advances in experimental medicine and biology (2014), pp. 401-435
Closed Access | Times Cited: 236
Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells
Lilly Bourguignon, Craig C. Earle, Garry Wong, et al.
Oncogene (2011) Vol. 31, Iss. 2, pp. 149-160
Open Access | Times Cited: 234
NOD-Like Receptors: Master Regulators of Inflammation and Cancer
Mansi Saxena, Garabet Yeretssian
Frontiers in Immunology (2014) Vol. 5
Open Access | Times Cited: 234
XIAP Restricts TNF- and RIP3-Dependent Cell Death and Inflammasome Activation
Monica Yabal, Nicole Müller, Heiko Adler, et al.
Cell Reports (2014) Vol. 7, Iss. 6, pp. 1796-1808
Open Access | Times Cited: 231
X-Linked Inhibitor of Apoptosis Protein – A Critical Death Resistance Regulator and Therapeutic Target for Personalized Cancer Therapy
Petra Obexer, Michael J. Ausserlechner
Frontiers in Oncology (2014) Vol. 4
Open Access | Times Cited: 209
Activatable nanomedicine for overcoming hypoxia-induced resistance to chemotherapy and inhibiting tumor growth by inducing collaborative apoptosis and ferroptosis in solid tumors
Jingke Fu, Tao Li, Yangzi Yang, et al.
Biomaterials (2020) Vol. 268, pp. 120537-120537
Closed Access | Times Cited: 196
Small-molecule SMAC mimetics as new cancer therapeutics
Longchuan Bai, David C. Smith, Shaomeng Wang
Pharmacology & Therapeutics (2014) Vol. 144, Iss. 1, pp. 82-95
Open Access | Times Cited: 188
NF-κB in cancer therapy
Feng Li, Jingwen Zhang, Frank Arfuso, et al.
Archives of Toxicology (2015) Vol. 89, Iss. 5, pp. 711-731
Closed Access | Times Cited: 179
NF-κB inhibitors in treatment and prevention of lung cancer
Rajan Radha Rasmi, Kunnathur Murugesan Sakthivel, Chandrasekaran Guruvayoorappan
Biomedicine & Pharmacotherapy (2020) Vol. 130, pp. 110569-110569
Open Access | Times Cited: 160
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xin Xie, Tingting Yu, Xiang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 154
A long way to go: caspase inhibitors in clinical use
Shanel Dhani, Yun Zhao, Boris Zhivotovsky
Cell Death and Disease (2021) Vol. 12, Iss. 10
Open Access | Times Cited: 117
Drug Resistance in Colorectal Cancer: From Mechanism to Clinic
Qianyu Wang, Xiaofei Shen, Gang Chen, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2928-2928
Open Access | Times Cited: 82
A Review of the Current Impact of Inhibitors of Apoptosis Proteins and Their Repression in Cancer
Pierina Cetraro, Julio Plaza‐Díaz, Alex MacKenzie, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1671-1671
Open Access | Times Cited: 77
Harnessing TRAIL-induced cell death for cancer therapy: a long walk with thrilling discoveries
Antonella Montinaro, Henning Walczak
Cell Death and Differentiation (2022) Vol. 30, Iss. 2, pp. 237-249
Open Access | Times Cited: 75

Scroll to top